Hineloran je leki koji deluje kao selektivni dopaminski agonist za D2 podtipe.[5][6][7]
Hineloran
|
| (IUPAC) ime
|
| (5aR,9aR)-6-propil-5a,7,8,9,9a,10-heksahidro-5H-pirido[2,3-g]hinazolin-2-amin
|
| Klinički podaci
|
| Identifikatori
|
| CAS broj
|
97548-97-5
|
| ATC kod
|
nije dodeljen
|
| PubChem[1][2]
|
57242
|
| UNII
|
Z0X4VT3Y1Q  Y
|
| KEGG[3]
|
D05677 Y
|
| ChEMBL[4]
|
CHEMBL155731 Y
|
| Hemijski podaci
|
| Formula
|
C14H22N4
|
| Mol. masa
|
246,350 g/mol
|
| SMILES
|
eMolekuli & PubHem
|
| InChI |
|---|
InChI=1S/C14H22N4/c1-2-5-18-6-3-4-10-7-12-11(8-13(10)18)9-16-14(15)17-12/h9-10,13H,2-8H2,1H3,(H2,15,16,17)/t10-,13-/m1/s1 Y
Key: TUFADSGTJUOBEH-ZWNOBZJWSA-N Y |
|
| Farmakoinformacioni podaci
|
| Trudnoća
|
?
|
| Pravni status
|
|
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
- ↑ Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J, Vallone D, Saiardi A, Borrelli E (April 2002). „Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists”. Journal of Neuroscience 22 (7): 2977–88. PMID 11923462.
- ↑ Gasior M, Paronis CA, Bergman J (January 2004). „Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys”. The Journal of Pharmacology and Experimental Therapeutics 308 (1): 249–59. DOI:10.1124/jpet.103.052795. PMID 14563783.
- ↑ Brooks JM, Sarter M, Bruno JP (September 2007). „D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex”. Neuropharmacology 53 (3): 455–63. DOI:10.1016/j.neuropharm.2007.06.006. PMC 2000917. PMID 17681559.
